348 related articles for article (PubMed ID: 20303530)
1. Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells.
Bae KM; Su Z; Frye C; McClellan S; Allan RW; Andrejewski JT; Kelley V; Jorgensen M; Steindler DA; Vieweg J; Siemann DW
J Urol; 2010 May; 183(5):2045-53. PubMed ID: 20303530
[TBL] [Abstract][Full Text] [Related]
2. Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.
Le Magnen C; Bubendorf L; Ruiz C; Zlobec I; Bachmann A; Heberer M; Spagnoli GC; Wyler S; Mengus C
Eur J Cancer; 2013 Mar; 49(4):955-63. PubMed ID: 23089465
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of the clinical significance of inducing pluripotent stemness-related gene expression in colorectal cancer cells.
Saiki Y; Ishimaru S; Mimori K; Takatsuno Y; Nagahara M; Ishii H; Yamada K; Mori M
Ann Surg Oncol; 2009 Sep; 16(9):2638-44. PubMed ID: 19554373
[TBL] [Abstract][Full Text] [Related]
4. A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells.
Zhang Y; Huang Y; Jin Z; Li X; Li B; Xu P; Huang P; Liu C
Tumour Biol; 2016 Sep; 37(9):11973-11981. PubMed ID: 27113741
[TBL] [Abstract][Full Text] [Related]
5. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells.
Masui S; Nakatake Y; Toyooka Y; Shimosato D; Yagi R; Takahashi K; Okochi H; Okuda A; Matoba R; Sharov AA; Ko MS; Niwa H
Nat Cell Biol; 2007 Jun; 9(6):625-35. PubMed ID: 17515932
[TBL] [Abstract][Full Text] [Related]
6. Gene dynamics of core transcription factors for pluripotency in embryonic stem cells.
David BG; Okamoto K; Kakizuka T; Ichimura T; Watanabe TM; Fujita H
J Biosci Bioeng; 2015 Apr; 119(4):406-9. PubMed ID: 25441442
[TBL] [Abstract][Full Text] [Related]
7. Induced pluripotent stem cell-related genes influence biological behavior and 5-fluorouracil sensitivity of colorectal cancer cells.
Shi Z; Bai R; Fu ZX; Zhu YL; Wang RF; Zheng S
J Zhejiang Univ Sci B; 2012 Jan; 13(1):11-9. PubMed ID: 22205615
[TBL] [Abstract][Full Text] [Related]
8. Gata4 blocks somatic cell reprogramming by directly repressing Nanog.
Serrano F; Calatayud CF; Blazquez M; Torres J; Castell JV; Bort R
Stem Cells; 2013 Jan; 31(1):71-82. PubMed ID: 23132827
[TBL] [Abstract][Full Text] [Related]
9. Reprogramming Prostate Cancer Cells into Induced Pluripotent Stem Cells: a Promising Model of Prostate Cancer Stem Cell Research.
Zhang Y; Chen B; Xu P; Liu C; Huang P
Cell Reprogram; 2020 Oct; 22(5):262-268. PubMed ID: 32816532
[TBL] [Abstract][Full Text] [Related]
10. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2--brief report.
Ho PJ; Yen ML; Lin JD; Chen LS; Hu HI; Yeh CK; Peng CY; Lin CY; Yet SF; Yen BL
Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1905-7. PubMed ID: 20689077
[TBL] [Abstract][Full Text] [Related]
11. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
[TBL] [Abstract][Full Text] [Related]
12. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
[TBL] [Abstract][Full Text] [Related]
13. Reprogramming of human somatic cells to pluripotency with defined factors.
Park IH; Zhao R; West JA; Yabuuchi A; Huo H; Ince TA; Lerou PH; Lensch MW; Daley GQ
Nature; 2008 Jan; 451(7175):141-6. PubMed ID: 18157115
[TBL] [Abstract][Full Text] [Related]
14. Induced overexpression of Oct4A in human dental pulp cells enhances pluripotency and multilineage differentiation capability.
Liu L; Wu L; Wei X; Ling J
Stem Cells Dev; 2015 Apr; 24(8):962-72. PubMed ID: 25422984
[TBL] [Abstract][Full Text] [Related]
15. Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma.
Holmberg J; He X; Peredo I; Orrego A; Hesselager G; Ericsson C; Hovatta O; Oba-Shinjo SM; Marie SK; Nistér M; Muhr J
PLoS One; 2011 Mar; 6(3):e18454. PubMed ID: 21483788
[TBL] [Abstract][Full Text] [Related]
16. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
Okada M; Yoneda Y
Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
[TBL] [Abstract][Full Text] [Related]
17. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
[TBL] [Abstract][Full Text] [Related]
18. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
Takahashi K; Yamanaka S
Cell; 2006 Aug; 126(4):663-76. PubMed ID: 16904174
[TBL] [Abstract][Full Text] [Related]
19. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
[TBL] [Abstract][Full Text] [Related]
20. Expression and role of Oct3/4, Nanog and Sox2 in regeneration of rat tracheal epithelium.
Song N; Jia XS; Jia LL; Ma XB; Li F; Wang EH; Li X
Cell Prolif; 2010 Feb; 43(1):49-55. PubMed ID: 19845688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
